All Posts By

admin

Closed
June 19, 2019

MERCK

A  Six  Month  Phase II/III,  Randomized, Double- Blind, PlaceboControlled   Clinical  Trial to Evaluate  the…
Read More
Closed
June 19, 2019

TAKEDA

A Multicenter, Randomized, Double-Blind,  Placebo-Controlled Study to Determine the Efficacy and Safety of Alogliptin Plus…
Read More
Closed
June 19, 2019

ABBOTT (M10889)

A Global Multicenter, Randomized,Double-Blind, Placebo- and  Active-Controlled Study Comparing the Analgesic Efficacy and Safety of…
Read More
Closed
June 19, 2019

ABBOTT (M12-073)

A Double-Blind, Randomized, Parellel-Arm,Multicenter Study to Determine the Dose Response of Methotrexate (MTX) in CombinationTherapy…
Read More
Closed
June 19, 2019

NOVARTIS (CACZ885M2301)

A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent…
Read More
Closed
June 19, 2019

NOVARTIS (CQVA149A2340)

A multi-center, randomized, double-blind, 52-week study to assess the safety of QVA149 compared to QAB149…
Read More
Closed
June 19, 2019

NOVARTIS (CAIN457F2302)

Novartis Pharmaceuticals trial entitled: A randomized, double-blind, placebo- controlled study of secukinumab to demonstrate the…
Read More
Closed
June 19, 2019

NOVARTIS (CAIN457F2206)

A randomized, double-blind, placebo-controlled regimen finding study of efficacy, safety and tolerability of secukinumab at…
Read More
Closed
June 19, 2019

ELI LILLY I4V-MC-JADW

“A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of  Baricitinib (LY3009104)…
Read More
Closed
June 19, 2019

ELI LILLY H9B-MC-BCDS

“A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of…
Read More